Lead party: Verod Capital Management Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Emzor Pharmaceutical Industries Limited (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Nigeria
Transaction type: Investment, Debt Financing · Asset class: Private Equity · Strategy: Direct Lending, Growth Equity · Instrument: Equity, Debt · Deal amount: US$15m · Equity stake: 0.308% · Fund: Verod Capital Growth Fund II
Lead investor/buyer: Verod Capital Management Limited · Investors/buyers: Verod Capital Management Limited
Legal advisers: not identified in the source record.
Source: announced 1 January 2018.


